Literature DB >> 25951352

Electroclinical features of epileptic encephalopathy caused by SCN8A mutation.

Satoru Takahashi1, Shiho Yamamoto1, Akie Okayama1, Akiko Araki1, Hirotomo Saitsu2, Naomichi Matsumoto2, Hiroshi Azuma1.   

Abstract

Voltage-gated sodium channel Nav 1.6, encoded by the gene SCN8A, plays a crucial role in controlling neuronal excitability. SCN8A mutations that cause increased channel activity are associated with seizures. We describe a patient with epileptic encephalopathy caused by de novo SCN8A mutation (c.5614C>T, p.Arg1872Trp). Seizures began 10 days after birth at which time brain magnetic resonance imaging (MRI) and electroencephalography (EEG) were normal. Seizure recurrence increased with age, leading to the development of frequent status epilepticus from 1 year of age. Seizure type included generalized tonic seizures and focal motor seizures. EEG first showed focal epileptic activity at the age of 4 months, and thereafter showed multifocal spikes. Serial MRI demonstrated brain atrophy, which appeared to progress with seizure aggravation. Clinical features that may give a clue to the diagnosis include normal EEG despite frequent seizures in early infancy and an increase in epileptic activity that occurs with aging.
© 2015 Japan Pediatric Society.

Entities:  

Keywords:  SCN8A; encephalopathy; epilepsy; mutation; sodium channel

Mesh:

Substances:

Year:  2015        PMID: 25951352     DOI: 10.1111/ped.12622

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  7 in total

1.  Precision Medicine: SCN8A Encephalopathy Treated with Sodium Channel Blockers.

Authors:  Rikke S Møller; Katrine M Johannesen
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

2.  SCN8A encephalopathy: Research progress and prospects.

Authors:  Miriam H Meisler; Guy Helman; Michael F Hammer; Brandy E Fureman; William D Gaillard; Alan L Goldin; Shinichi Hirose; Atsushi Ishii; Barbara L Kroner; Christoph Lossin; Heather C Mefford; Jack M Parent; Manoj Patel; John Schreiber; Randall Stewart; Vicky Whittemore; Karen Wilcox; Jacy L Wagnon; Phillip L Pearl; Adeline Vanderver; Ingrid E Scheffer
Journal:  Epilepsia       Date:  2016-06-08       Impact factor: 5.864

Review 3.  Ion Channels in Genetic Epilepsy: From Genes and Mechanisms to Disease-Targeted Therapies.

Authors:  Julia Oyrer; Snezana Maljevic; Ingrid E Scheffer; Samuel F Berkovic; Steven Petrou; Christopher A Reid
Journal:  Pharmacol Rev       Date:  2018-01       Impact factor: 25.468

4.  Prominent role of forebrain excitatory neurons in SCN8A encephalopathy.

Authors:  Rosie K A Bunton-Stasyshyn; Jacy L Wagnon; Eric R Wengert; Bryan S Barker; Alexa Faulkner; Pravin K Wagley; Kritika Bhatia; Julie M Jones; Marissa R Maniaci; Jack M Parent; Howard P Goodkin; Manoj K Patel; Miriam H Meisler
Journal:  Brain       Date:  2019-02-01       Impact factor: 13.501

5.  Pathogenic mechanism of recurrent mutations of SCN8A in epileptic encephalopathy.

Authors:  Jacy L Wagnon; Bryan S Barker; James A Hounshell; Charlotte A Haaxma; Amy Shealy; Timothy Moss; Sumit Parikh; Ricka D Messer; Manoj K Patel; Miriam H Meisler
Journal:  Ann Clin Transl Neurol       Date:  2015-12-21       Impact factor: 4.511

6.  SCN8A mutations in Chinese patients with early onset epileptic encephalopathy and benign infantile seizures.

Authors:  Jiaping Wang; Hua Gao; Xinhua Bao; Qingping Zhang; Jiarui Li; Liping Wei; Xiru Wu; Yan Chen; Shujie Yu
Journal:  BMC Med Genet       Date:  2017-09-18       Impact factor: 2.103

7.  Gabra2 is a genetic modifier of Scn8a encephalopathy in the mouse.

Authors:  Wenxi Yu; Sophie F Hill; James G Xenakis; Fernando Pardo-Manuel de Villena; Jacy L Wagnon; Miriam H Meisler
Journal:  Epilepsia       Date:  2020-11-02       Impact factor: 5.864

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.